CAS 229177-52-0
:2-Cyclopentène-1-méthanol, 4-amino-, (1S,4R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (sel)
- (1S,4R)-4-Amino-2-cyclopentene-1-methanol (2S,3S)-2,3-dihydroxybutanedioate (1:1) salt
- (1S-cis)-4-Amino-2-cyclopentene-1-menthanol D-hydrogen tatrate
- 2-Cyclopentene-1-methanol, 4-amino-, (1S,4R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (salt)
- [(1S,4R)-4-aminocyclopent-2-en-1-yl]methanol 2,3-dihydroxybutanedioate (1:1)
(1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol D-Tartrate
CAS :Formule :C10H17NO7Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :263.2445(1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol D-Tartrate
CAS :Produit contrôléImpurity Abacavir - In House Impurity
Applications (1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol D-Tartrate (Abacavir - In House Impurity) is an intermediate of Abacavir (A104990). Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor and an anti-HIV drug used to treat HIV infection (1). Intracellular enzymes convert Abacavir to its active form, carbovir-triphosphate (CBV-TP), which then selectively inhibits HIV reverse transcriptase by incorporating into viral DNA (2). Abacavir is metabolized in the liver by uridine diphosphate glucuronyltransferase and alcohol dehydrogenase resulting in inactive glucuronide and carboxylate metabolites, respectively.
References (1) Jackson, A., et al.: Antivir Ther. 17, 19 (2012) (2) Yuen, G. J., et al.: Clin Pharmacokinet. 47, 351 (2008)Formule :C6H11NO·C4H6O6Couleur et forme :NeatMasse moléculaire :263.24(1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol D-Tartrate
CAS :Formule :C6H11NOC4H6O6Masse moléculaire :113.16 : 150.09



